RNA-mediated toxicity in C9orf72 ALS and FTD

被引:28
|
作者
McEachin, Zachary T. [1 ,2 ]
Parameswaran, Janani [1 ]
Raj, Nisha [1 ,2 ]
Bassell, Gary J. [1 ,2 ,3 ]
Jiang, Jie [1 ]
机构
[1] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA
[2] Emory Univ, Lab Translat Cell Biol, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
关键词
Amyotrophic lateral sclerosis; Frontotemporal dementia; C9orf72; RNA-mediated toxicity; RNA foci; Dipeptide repeat proteins; Antisense oligonucleotide; FRONTOTEMPORAL LOBAR DEGENERATION; DIPEPTIDE REPEAT PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; PATHOLOGICAL FEATURES; ANTISENSE RNA; MUSCLEBLIND PROTEINS; TDP-43; PATHOLOGY; SMALL MOLECULES; IN-VITRO;
D O I
10.1016/j.nbd.2020.105055
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A GGGGCC hexanucleotide repeat expansion in the first intron of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Compelling evidence suggests that gain of toxicity from the bidirectionally transcribed repeat expanded RNAs plays a central role in disease pathogenesis. Two potential mechanisms have been proposed including RNA-mediated toxicity and/or the production of toxic dipeptide repeat proteins. In this review, we focus on the role of RNA mediated toxicity in ALS/FTD caused by the C9orf72 mutation and discuss arguments for and against this mechanism. In addition, we summarize how G4C2 repeat RNAs can elicit toxicity and potential therapeutic strategies to mitigate RNA-mediated toxicity.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
    Martier, Raygene
    Liefhebber, Jolanda M.
    Garcia-Osta, Ana
    Miniarikova, Jana
    Cuadrado-Tejedor, Mar
    Espelosin, Maria
    Ursua, Susana
    Petry, Harald
    van Deventer, Sander J.
    Evers, Melvin M.
    Konstantinova, Pavlina
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 26 - 37
  • [2] Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
    Kumar, Vijay
    Hasan, Gulam M.
    Hassan, Md. Imtaiyaz
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [3] C9orf72 RNA foci—a therapeutic target for ALS and FTD?
    Heather Wood
    Nature Reviews Neurology, 2013, 9 (12) : 659 - 659
  • [4] RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
    Donnelly, Christopher J.
    Zhang, Pingwu
    Vidensky, Svetlana
    Daley, Elizabeth
    Hoover, Benjamin
    Traynor, Bryan
    Rigo, Frank
    Bennett, Frank
    Seth, Blackshaw
    Sattler, Rita
    Rothstein, Jeffrey D.
    Rothstein, Jeffrey D.
    ANNALS OF NEUROLOGY, 2013, 74 : S63 - S63
  • [5] RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
    Donnelly, Christopher J.
    Zhang, Ping-Wu
    Pham, Jacqueline T.
    Heusler, Aaron R.
    Mistry, Nipun A.
    Vidensky, Svetlana
    Daley, Elizabeth L.
    Poth, Erin M.
    Hoover, Benjamin
    Fines, Daniel M.
    Maragakis, Nicholas
    Tienari, Pentti J.
    Petrucelli, Leonard
    Traynor, Bryan J.
    Wang, Jiou
    Rigo, Frank
    Bennett, C. Frank
    Blackshaw, Seth
    Sattler, Rita
    Rothstein, Jeffrey D.
    NEURON, 2013, 80 (02) : 415 - 428
  • [6] Verbal Fluency in C9orf72 ALS/FTD
    Braun, L.
    Floeter, M.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2015, 30 (06) : 555 - 555
  • [7] Realizing the gains and losses in C9ORF72 ALS/FTD
    Cathleen Lutz
    Nature Neuroscience, 2020, 23 : 596 - 597
  • [8] Realizing the gains and losses in C9ORF72 ALS/FTD
    Lutz, Cathleen
    NATURE NEUROSCIENCE, 2020, 23 (05) : 596 - 597
  • [9] C9orf72 repeat expansions in patients with ALS and FTD
    Rademakers, Rosa
    LANCET NEUROLOGY, 2012, 11 (04): : 297 - 298
  • [10] The C9orf72 hexanucleotide repeat expansion in FTD and ALS
    Eileen H. Bigio
    Nature Reviews Neurology, 2012, 8 : 249 - 250